Benitec Biopharma Inc.
Company Stats
- Market Cap
- $348.8M
- as of Sep 30, 2026
- Shares Outstanding
- 34.9M
- Free Float
- 38.1%
Income Statement
- Operating Income
- -$51.2M
- Net Income
- -$45.5M
- EBITDA
- -$51.1M
Cash Flow
- Free Cash Flow
- -$16.6M
- FCF Yield
- -4.8%
- Owner FCF Yield
- -12.3%
Balance Sheet
- Cash & Equivalents
- $180.0M
Returns & Capital
- SBC, 3Y Avg
- $14.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2026 | — | -$16.6M | — |
| FY2025 | — | -$23.6M | — |
| FY2024 | $0 | -$19.6M | — |
| FY2023 | $75,000 | -$18.0M | -24017.3% |
| FY2022 | $73,000 | -$15.9M | -21797.3% |
Annual filing data through FY ended June 30, 2026; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges